Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2026-05-14 Declaration of Voting R…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Treść uchwał podjętych oraz uchwał niepoddanych pod głosowanie przez Nadzwyczajne Walne Zgromadzenie Pure Biologics S.A. 14 maja 2026 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document provides the resolutions adopted and not put to vote by the Extraordinary General Meeting held on May 14, 2026, along with the number of shares voted, percentage of share capital, and votes “for”, “against” and “abstained”. This is a formal declaration of voting results from a general meeting, matching the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-14 Polish
Zmiana terminu publikacji raportu kwartalnego za I kwartał 2026 r. - Content (PL)
Report Publication Announcement Classification · 80% confidence The document is a brief notice informing investors of a change in the publication date for the Q1 2026 report. It contains no financial statements or substantive data, only an announcement of timing of a forthcoming report. Under the “menu vs meal” rule, this is a report publication announcement rather than the interim report itself.
2026-05-12 Polish
Informacja dotycząca opóźnienia w przekazaniu raportu rocznego oraz nowego terminu jego publikacji - Content (PL)
Report Publication Announcement Classification · 92% confidence The document is a short announcement (under 5,000 characters) stating that the company’s annual report for the year 2025 will be released later than originally planned, with a new publication date set. It does not contain any financial statements or analysis itself, but merely informs investors of the timing of the report publication. Under the “Menu vs Meal” rule, this is a Report Publication Announcement rather than the report itself.
2026-04-29 Polish
Projekty uchwał NWZ
Share Issue/Capital Change Classification · 88% confidence The document is the text of resolutions (Uchwały) adopted by an Extraordinary General Meeting of Pure Biologics S.A. concerning the issuance of new share capital series Q, R, S, dematerialisation, private subscription, amendment of the company’s statutes, and related corporate actions. This is a direct announcement of a new share issue/capital change and not merely a report publication or earnings release. Accordingly, it best fits the “Share Issue/Capital Change” category (Code: SHA).
2026-04-17 Polish
Ogłoszenie o zwołaniu NWZ
Proxy Solicitation & Information Statement Classification · 75% confidence The document is an official notice convening an Extraordinary General Meeting (EGM) of shareholders, detailing the date, agenda items, and procedures for participation, voting, and proxy submission. This aligns with materials sent to shareholders to provide information and solicit votes for a corporate meeting, fitting the Proxy Solicitation & Information Statement category.
2026-04-17 Polish
Informacja o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Pure Biologics S.A. wraz z treścią projektów uchwał - Content (PL)
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a current report under Polish MF regulation announcing and convening an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) and providing draft resolutions and meeting materials to shareholders. It is not reporting voting results, nor financial results, nor is it an annual or interim report, but is supplying information and soliciting votes for a shareholder meeting. This best aligns with Proxy Solicitation & Information Statement (PSI).
2026-04-17 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.